SEDLAŘÍKOVÁ, Lenka, Božena BOLLOVÁ, Lenka RADOVÁ, Lucie BROŽOVÁ, Jiří JARKOVSKÝ, Martina ALMÁŠI, Miroslav PENKA, Petr KUGLÍK, Viera SANDECKÁ, Martin ŠTORK, Luděk POUR and Sabina ŠEVČÍKOVÁ. Circulating exosomal long noncoding RNA PRINS-First findings in monoclonal gammopathies. Hematological Oncology. MALDEN, USA: WILEY-BLACKWELL, 2018, vol. 36, No 5, p. 786-791. ISSN 0278-0232. Available from: https://dx.doi.org/10.1002/hon.2554.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Circulating exosomal long noncoding RNA PRINS-First findings in monoclonal gammopathies
Authors SEDLAŘÍKOVÁ, Lenka (203 Czech Republic, belonging to the institution), Božena BOLLOVÁ (703 Slovakia, belonging to the institution), Lenka RADOVÁ (203 Czech Republic, belonging to the institution), Lucie BROŽOVÁ (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Martina ALMÁŠI (203 Czech Republic), Miroslav PENKA (203 Czech Republic), Petr KUGLÍK (203 Czech Republic, belonging to the institution), Viera SANDECKÁ (703 Slovakia), Martin ŠTORK (203 Czech Republic), Luděk POUR (203 Czech Republic) and Sabina ŠEVČÍKOVÁ (203 Czech Republic, guarantor, belonging to the institution).
Edition Hematological Oncology, MALDEN, USA, WILEY-BLACKWELL, 2018, 0278-0232.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30205 Hematology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.439
RIV identification code RIV/00216224:14110/18:00106959
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1002/hon.2554
UT WoS 000452625700009
Keywords in English biomarker; long noncoding RNA; monoclonal gammopathy of undetermined significance; multiple myeloma; qPCR
Tags 14110518, 14119612, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 18/3/2019 12:17.
Abstract
Multiple myeloma is the second most common hematological malignancy characterized by focal lesions of malignant plasma cells in the bone marrow. These lesions contain subclones that directly influence survival of patients. Bone marrow biopsies are single-site biopsies and thus cannot contain all information about the tumor. In contrast, liquid biopsies analyze circulating cells and molecules that are secreted from all sites of the tumor. Long noncoding RNA molecules are one class of these molecules. We performed a two-phase biomarker study investigating lncRNA expression profiles in exosomes of peripheral blood serum of newly diagnosed multiple myeloma (MM) patients, monoclonal gammopathy of undetermined significance (MGUS) patients in comparison with healthy donors (HD). Surprisingly, this analysis revealed dysregulation of only one exosomal lncRNA PRINS in MM vs HD. Overall, MM and MGUS patients were distinguished from HD with sensitivity of 84.9% and specificity of 83.3%. Our study suggests a possible diagnostic role for exosomal lncRNA PRINS in monoclonal gammopathies patients.
Links
NV15-29508A, research and development projectName: Cirkulující nukleové kyseliny jako markery progrese mnohočetného myelomu
PrintDisplayed: 13/7/2024 17:06